Ionis Pharmaâs drug to treat rare genetic disease gets US regulator’s nodÂ
The US Food and Drug Administration has approved Ionis Pharmaceuticalsâ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
The US Food and Drug Administration has approved Ionis Pharmaceuticalsâ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia.